logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8975399 B1

PDFFull Text
Expired
Date of Patent:
Mar. 10, 2015

Filed:

Jul. 19, 2011

Benzenesulfon amide-compound treatment of a pathological condition linked to an excessive effect of tnf

Applicants:

Jean-francois Zagury, Paris, FR;

Matthieu Montes, Paris, FR;

Hadley Mouhsine, Kremlin Bicetre, FR;

Helene Guillemain, Conflans Sainte Honorine, FR;

Inventors:

Jean-Francois Zagury, Paris, FR;

Matthieu Montes, Paris, FR;

Hadley Mouhsine, Kremlin Bicetre, FR;

Helene Guillemain, Conflans Sainte Honorine, FR;

Assignee:

Other;

Attorney:

Browdy and Neimark, PLLC

Primary Examiner:

Erich A Leeser

Int. Cl.
CPC ...
A61K 45/06 (2006.01); A61K 31/343 (2006.01); A61K 31/495 (2006.01); A61K 31/502 (2006.01); A61K 31/18 (2006.01); A61K 31/352 (2006.01); A61K 31/403 (2006.01); C07C 311/21 (2006.01); C07C 311/29 (2006.01); C07D 207/38 (2006.01); C07D 207/48 (2006.01); C07D 295/185 (2006.01); C07D 295/215 (2006.01); C07D 295/26 (2006.01); C07D 307/79 (2006.01); C07D 307/91 (2006.01); C07D 307/92 (2006.01); C07D 309/38 (2006.01); C07D 317/66 (2006.01); C07D 319/18 (2006.01); C07D 405/12 (2006.01); C07D 237/34 (2006.01); C07D 241/04 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 2121/00 (2013.01); A61K 31/18 (2013.01); A61K 31/343 (2013.01); A61K 31/352 (2013.01); A61K 31/403 (2013.01); A61K 31/495 (2013.01); A61K 31/502 (2013.01); C07C 311/21 (2013.01); C07C 311/29 (2013.01); C07C 2103/20 (2013.01); C07D 207/38 (2013.01); C07D 207/48 (2013.01); C07D 295/185 (2013.01); C07D 295/215 (2013.01); C07D 295/26 (2013.01); C07D 307/79 (2013.01); C07D 307/91 (2013.01); C07D 307/92 (2013.01); C07D 309/38 (2013.01); C07D 317/66 (2013.01); C07D 319/18 (2013.01); C07D 405/12 (2013.01); C07D 237/34 (2013.01); C07D 241/04 (2013.01);
Abstract

A benzene sulphonamide compound of formula I or one of its addition salts with pharmaceutically acceptable acids, for its use in a method for treating a pathology linked to an excessive effect of TNF-alpha and for its use in a method for treating the human or animal body as a direct inhibitor of TNF-alpha.

Find Patent Forward Citations

Zagury, Jean-Francois. (2015). Benzenesulfon amide-compound treatment of a pathological condition linked to an excessive effect of tnf (U.S. Patent No. 8975399). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8975399

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…